| 20/03 | Lensar : LNSR Corporate Presentation March 2023 |  |
| 16/03 | LENSAR, INC. Management's Discussion and Analysis of Financial Condition and Results
o.. | |
| 16/03 | Earnings Flash (LNSR) LENSAR Reports Q4 Revenue $10.2M, vs. Street Est of $10M | |
| 16/03 | LENSAR, Inc. Provides Revenue Guidance for the Fiscal 2023 | |
| 16/03 | LENSAR, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended Decemb.. | |
| 16/03 | LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update | |
| 09/03 | LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March.. | |
| 14/02 | LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results | |
| 14/02 | LENSAR, Inc. Announces Revenue Results for the Quarter and Year Ended December 31, 2022 | |
| 13/01 | Lensar, Inc. : Change in Directors or Principal Officers (form 8-K) | |
| 2022 | LENSAR to Present at Two Upcoming Investor Conferences | |
| 2022 | Lensar : November 2022 Corporate Presentation | |
| 2022 | LENSAR, INC. Management's Discussion and Analysis of Financial Condition and Results
o.. | |
| 2022 | LENSAR, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septe.. | |
| 2022 | Earnings Flash (LNSR) LENSAR Posts Q3 Revenue $7.7M, vs. Street Est of $7.9M | |
| 2022 | LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update | |
| 2022 | LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022 | |
| 2022 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from S&P Global BMI Index | |
| 2022 | LENSAR Applies for EU Certification of ALLY Adaptive Cataract Treatment System | |
| 2022 | Lensar, Inc. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (.. | |
| 2022 | Lensar, Inc. Announces Application for Certification of the Ally Adaptive Cataract Trea.. | |
| 2022 | LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Tre.. | |
| 2022 | Lensar : First Patients Treated with LENSAR's® ALLY™ Adaptive Cataract Treatment Sys.. | |
| 2022 | Lensar, Inc. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (.. | |
| 2022 | First Patients Treated with LENSAR's® ALLY™ Adaptive Cataract Treatment System | |
| 2022 | LENSAR, Inc. Announces First Patients Treated with LENSAR's(R) ALLY(TM) Adaptive Catara.. | |
| 2022 | LENSAR, INC. Management's Discussion and Analysis of Financial Condition and Results
o.. | |
| 2022 | Lensar : Reports Second Quarter 2022 Financial Results and Provides Business Update - Form.. | |
| 2022 | LENSAR, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June .. | |
| 2022 | Earnings Flash (LNSR) LENSAR Reports Q2 Revenue $8M | |
| 2022 | LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update | |
| 2022 | LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022 | |
| 2022 | Lensar, Inc. : Other Events (form 8-K) | |
| 2022 | LENSAR, Inc.(NasdaqCM:LNSR) added to Russell Microcap Growth Index | |
| 2022 | LENSAR, Inc.(NasdaqCM:LNSR) added to Russell 3000E Growth Index | |
| 2022 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell Microcap Value In.. | |
| 2022 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 3000E Value Index | |
| 2022 | Lensar : reg; Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment Syste.. | |
| 2022 | Lensar, Inc. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (.. | |
| 2022 | LENSAR Secures FDA Clearance of ALLY Adaptive Cataract Treatment System | |
| 2022 | LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System | |
| 2022 | LENSAR, Inc. Receives U.S. FDA Clearance of Ally(Tm) Adaptive Cataract Treatment System | |
| 2022 | Lensar Gets FDA 510(k) Clearance for ALLY Adaptive Cataract Treatment System | |
| 2022 | Lensar, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K) | |
| 2022 | LENSAR, INC. Management's Discussion and Analysis of Financial Condition and Results
.. | |
| 2022 | LENSAR, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 2022 | Earnings Flash (LNSR) LENSAR Posts Q1 Revenue $9.3M, vs. Street Est of $8.71M | |
| 2022 | LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update | |
| 2022 | LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022 | |
| 2022 | LENSAR, INC. Management's Discussion and Analysis of Financial Condition and Results
o.. | |
| 2022 | Lensar : Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business.. | |
| 2022 | LENSAR, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 2022 | LENSAR, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 | |
| 2022 | Earnings Flash (LNSR) LENSAR Reports Q4 Revenue $11.2M, vs. Street Est of $8.9M | |
| 2022 | LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Busines.. | |
| 2022 | Lensar, Inc. : Other Events (form 8-K) | |
| 2022 | LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for .. | |
| 2022 | LENSAR, Inc. Announces U.S. Food and Drug Administration Acceptance of 510(k) Submissio.. | |
| 2022 | LENSAR to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March.. | |
| 2022 | LENSAR to Participate in Two Upcoming Investor Conferences | |
| 2022 | Lensar Names Kendra Wong Principal Accounting Officer | |
| 2022 | Lensar, Inc. : Change in Directors or Principal Officers (form 8-K) | |
| 2022 | LENSAR, Inc. Appoints Kendra W. Wong as Principal Accounting Officer | |
| 2022 | LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference | |
| 2021 | LENSAR to Present at Two Upcoming Investor Conferences | |
| 2021 | LENSAR Announces Poster Presentations at the American Academy of Ophthalmology | |
| 2021 | LENSAR, Inc Corporate Presentation | |
| 2021 | LENSAR, INC. Management's Discussion and Analysis of Financial Condition and Results
.. | |
| 2021 | LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update - Form.. | |
| 2021 | LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update | |
| 2021 | Earnings Flash (LNSR) LENSAR Reports Q3 Revenue $8.3M, vs. Street Est of $7.67M | |
| 2021 | LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021 | |
| 2021 | Lensar : to Present at the H.C. Wainwright 23rd Annual Global Investment Conference | |
| 2021 | Lensar : to Present at the H.C. Wainwright Ophthalmology Virtual Conference | |
| 2021 | Lensar : Corporate Presentation | |
| 2021 | Lensar : Management's Discussion and Analysis of Financial Condition and Results of Operat.. | |
| 2021 | Lensar, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 | |
| 2021 | LENSAR : Earnings Flash (LNSR) LENSAR Posts Q2 Revenue $7.9M, vs. Street Est of $.. | |
| 2021 | Lensar : Reports Second Quarter 2021 Financial Results and Provides Business Update | |
| 2021 | Lensar : to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021 | |
| 2021 | Lensar : Announces In-Person Demonstrations of Its Next Generation ALLY™ System and .. | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 2000 Index | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell Small Cap Complet.. | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell Small Cap Comp Va.. | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 3000 Index | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 3000E Index | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 3000 Value Index | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 2000 Value-Defens.. | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 2000 Defensive In.. | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 2000 Dynamic Inde.. | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 2500 Value Index | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 2000 Value Index | |
| 2021 | LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 2500 Index | |
| 2021 | Lensar : to Present at the Oppenheimer MedTech, Tools, & Diagnostics Summit | |
| 2021 | Lensar, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K) | |
| 2021 | Lensar : Management's Discussion and Analysis of Financial Condition and Results of Operat.. | |
| 2021 | LENSAR : Earnings Flash (LNSR) LENSAR Posts Q1 Revenue $7M, vs. Street Est of $6... | |
| 2021 | Lensar : Reports First Quarter 2021 Financial Results and Provides Business Update | |
| 2021 | LENSAR, Inc. Announces Earnings Results for the First Quarter Ended March 31, 2021 | |
| 2021 | Lensar : to Hold First Quarter 2021 Financial Results Conference Call on Wednesday, May 5,.. | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
